header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O3159 METAL ION LEVELS IN PATIENTS WITH METAL ON METAL SURFACE ARTHROPLASTY



Abstract

Aims: Measure serum chromium (SrCr) and cobalt (SrCo) and urine chromium (UCr) levels in patients with metal on metal surface arthroplasty of the hip. Methods: Ion levels were measured prospectively in 22 patients implanted with the Conserve Plusª (Wright Medical, TN) CoCr hip resurfacing. There were 15 males and 7 females with an average age of 49 years (range 28 Ð 62 yr). Serum and urine samples were collected using strict anti-contamination techniques pre-operatively and at 3, 6 and 12 months using graphite furnace atomic absorption spectrophotometry. Results: All postoperative metal levels were increased compared to their pre-operative levels. SrCr and SrCo values are at their highest at 3 months post operative and then begin to decrease. UrCr although elevated at 3 and 6 months postoperatively compared to the preop values, the levels continued to increase after the 6-month interval. These values are approximately 4-fold, 7-fold and 3-fold higher in SrCr, UrCr and SrCo, respectively, compared to the values seen in a group of patients with well functioning conventional metal (CoCr) on polyethylene total hips at 84 months postoperative measured by our group. Conclusions: The present levels are 2-fold lower in both SrCr and UrCr and 3-fold lower in SrCo than a group of patients with older generation surface arthroplasties reported previously by our group, suggesting improved manufacturing techniques and material properties have resulted in reduced component wear and generation of wear particles. 12 and 24 month data are currently being collected and analyzed.

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.